Milnacipran in the treatment of bulimia nervosa: a report of 16 cases

Author： El-Giamal N.   de Zwaan M.   Bailer U.   Strnad A.   Schussler P.   Kasper S.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.13, Iss.2, 2003-03, pp. : 73-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluoxetine treatment of bulimia nervosa

By Vega M.   Chinchilla A.   Cebollada A.   Padiacute n J.J.   Guzmaacute n G.   Diacute az M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 287-288

Elsevier

Access to resources Recommend Favorite

Aetiopathogenesis and Pathophysiology of Bulimia Nervosa: Biological Bases and Implications for Treatment

By Brambilla F.  

CNS Drugs, Vol. 15, Iss. 2, 2001-01 ,pp. : 119-136

Adis International

Access to resources Recommend Favorite

Therapeutic approaches to bulimia nervosa

By Spigset O.   Hägg S.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 3, 2001-03 ,pp. : 463-477

Informa Healthcare

Access to resources Recommend Favorite

Management of Psychiatric Comorbidity in Anorexia Nervosa and Bulimia Nervosa

By Woodside Blake D.   Staab Randolf  

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 655-663

Adis International

Access to resources Recommend Favorite

Gastrointestinal Disturbances in Anorexia Nervosa and Bulimia Nervosa

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 1, 2003-02 ,pp. : 1-9

Bentham Science Publishers

Access to resources Recommend Favorite